Quantity size:
0.1ml
Concentration:
1mg/ml磷酸化胰岛素受体底物-1抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Insulin receptor substrates (IRS) are responsible for several insulin related activities, such as glucose homeostasis, cell growth, cell transformation, apoptosis and insulin signal transduction. Serine/threonine phosphorylation of IRS1 has been demonstrated to be a negative regulator of insulin signaling and is responsible for its degradation,磷酸化胰岛素受体底物-1抗体 although IRS1 degradation pathways are not well understood. IRS1 has also been shown to be constitutively activated in cancers such as breast cancer, Wilm's tumors, and adrenal cortical carcinomas, thus making IRS1 phosphorylation and subsequent degradation an attractive therapeutic target. To date there have been four subtypes identified: IRS1, 2, 3 and 4, with IRS1 being widely expressed.
磷酸化胰岛素受体底物-1抗体Also known as:
p-IRS1; IRS1(phospho-Ser789); IRS1 (phospho S789); p-IRS1 (phospho S789); HIRS 1; HIRS1; Insulin Receptor Substrate 1; IRS-1; IRS 1; IRS1; OTTHUMP00000164234; IRS1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, 磷酸化胰岛素受体底物-1抗体affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthesised phosphopeptide derived from human.
●
Predicted Molecular Weight: 132kDa.
磷酸化胰岛素受体底物-1抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl762Hu01叉头框蛋白O3(FOXO3)多克隆抗体Polyclonal Antibody to Forkhead Box Protein O3 (FOXO3)
kl762Mu01叉头框蛋白O3(FOXO3)多克隆抗体Polyclonal Antibody to Forkhead Box Protein O3 (FOXO3)
kl764Hu01叉头框蛋白O1(FOXO1)多克隆抗体Polyclonal Antibody to Forkhead Box Protein O1 (FOXO1)
kl766Hu01解整合素金属蛋白酶10(ADAM10)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloprotease 10 (ADAM10)
kl766Ra01解整合素金属蛋白酶10(ADAM10)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloprotease 10 (ADAM10)
kl768Hu01足盂蛋白(PCX)多克隆抗体Polyclonal Antibody to Podocalyxin (PCX)
kl768Mu01足盂蛋白(PCX)多克隆抗体Polyclonal Antibody to Podocalyxin (PCX)
kl770Hu01胱天蛋白酶5(CASP5)多克隆抗体Polyclonal Antibody to Caskle 5 (CASP5)
kl771Hu01趋化因子C-X-C-基元配体16(CXCL16)多克隆抗体Polyclonal Antibody to Chemokine C-X-C-Motif Ligand 16 (CXCL16)
kl771Ra01趋化因子C-X-C-基元配体16(CXCL16)多克隆抗体Polyclonal Antibody to Chemokine C-X-C-Motif Ligand 16 (CXCL16)
kl775Hu01己糖激酶1(HK1)多克隆抗体Polyclonal Antibody to Hexokinase 1 (HK1)
kl775Mu01己糖激酶1(HK1)多克隆抗体Polyclonal Antibody to Hexokinase 1 (HK1)
kl776Hu01丙酮酸脱氢酶α(PDHα)多克隆抗体Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl776Mu01丙酮酸脱氢酶α(PDHα)多克隆抗体Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl776Ra01丙酮酸脱氢酶α(PDHα)多克隆抗体Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl777Hu01T-细胞可诱导共刺激分子(ICOS)多克隆抗体Polyclonal Antibody to Inducible T-Cell Co Stimulator (ICOS)
kl778Hu01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Mu01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Po01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Ra01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl781Hu01CD276分子(CD276)多克隆抗体Polyclonal Antibody to Cluster Of Differentiation 276 (CD276)
kl782Ga01碳酸酐酶Ⅱ(CA2)多克隆抗体Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl782Hu01碳酸酐酶Ⅱ(CA2)多克隆抗体Polyclonal Antibody to Carbonic Anhydrase II (CA2)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话